Dianthus Therapeutics DNTH Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Dianthus Therapeutics’s reported figures.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Dianthus Therapeutics's enterprise value?
- Dianthus Therapeutics (DNTH) reported enterprise value of $3.82B in Q1 2026.
- How has Dianthus Therapeutics's enterprise value changed year-over-year?
- Dianthus Therapeutics's enterprise value increased by 564.9% year-over-year, from $574.03M to $3.82B.
- What is the long-term trend for Dianthus Therapeutics's enterprise value?
- Over 3 years (2022 to 2025), Dianthus Therapeutics's enterprise value has grown at a 254.5% compound annual growth rate (CAGR), from $38.55M to $1.72B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.